Axel Bauer, Nikolay Sappler, Lukas von Stülpnagel, Mathias Klemm, Michael Schreinlechner, Felix Wenner, Johannes Schier, Amani Al Tawil, Theresa Dolejsi, Aresa Krasniqi, Elodie Eiffener, Christa Bongarth, Markus Stühlinger, Martin Huemer, Tommaso Gori, Reza Wakili, Riza Sahin, Robert Schwinger, Matthias Lutz, Armin Luik, Nele Gessler, Peter Clemmensen, Axel Linke, Lars S Maier, Martin Hinterseer, Mathias C Busch, Florian Blaschke, Stefan Sack, Carsten Lennerz, Manuela Licka, Roland R Tilz, Christian Ukena, Joachim R Ehrlich, Markus Zabel, Georg Schmidt, Ulrich Mansmann, Stefan Kääb, Konstantinos D Rizas, Steffen Massberg
BACKGROUND: Cardiac autonomic dysfunction after myocardial infarction identifies patients at high risk despite only moderately reduced left ventricular ejection fraction. We aimed to show that telemedical monitoring with implantable cardiac monitors in these patients can improve early detection of subclinical but prognostically relevant arrhythmic events. METHODS: We did a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial at 33 centres in Germany and Austria...
February 2022: The Lancet. Digital health